Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2006
Small dsRNAs induce transcriptional activation in human cellsLong-Cheng Li, Steven T Okino, Hong Zhao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinomaHiroaki Shiina, Mikio Igawa, Julia Breault, et al.Cancer Research|April 17, 2008
Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modificationShahana Majid, Nobuyuki Kikuno, Jason Nelles, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancerKen Kawamoto, Steven T Okino, Robert F Place, et al.International Journal of Cancer|April 1, 2005
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancerHideki Enokida, Hiroaki Shiina, Shinji Urakami, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2006
Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancerYuichiro Tanaka, Masahiro Sasaki, Hiroaki Shiina, et al.Journal for Immunotherapy of Cancer|November 27, 2020
Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4Lisa A Marshall, Sachie Marubayashi, Aparna Jorapur, et al.Molecular Cancer Therapeutics|August 14, 2020
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity In Vitro and In VivoYamini M Ohol, Michael T Sun, Gene Cutler, et al.Journal of Medicinal Chemistry|July 2, 2019
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor MicroenvironmentJeffrey J Jackson, John M Ketcham, Ashkaan Younai, et al.Journal of Medicinal Chemistry|April 18, 2020
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor ActivityPaul R Leger, Dennis X Hu, Berenger Biannic, et al.Pageof 3